Private Advisor Group’s Regenxbio RGNX Stock Holding History

Private Advisor Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-250	Closed	-$9K	–	3026
2020 Q2	$9K	Buy	+250	New	+$9.32K	﹤0.01%	2992

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Private Advisor Group's RGNX Position: Q3 2020 in Review

Private Advisor Group sold out of Regenxbio (RGNX) in Q3 2020, closing a stake of 250 shares — an estimated $9K sold.

Private Advisor Group first reported a position in RGNX in Q2 2020 and held it in 1 quarter. The position peaked at $9K in Q2 2020. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2020.

Private Advisor Group reported no remaining Regenxbio position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 250 Regenxbio shares in Q3 2020, an estimated $9K.
Private Advisor Group first reported a position in Regenxbio in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Regenxbio position peaked at $9K in Q2 2020.
166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.